Inhibitory Effects of Nicardipine to Cytochrome P450 (CYP) in Human Liver Microsomes-Reference-Cited by-同舟云学术

Inhibitory Effects of Nicardipine to Cytochrome P450 (CYP) in Human Liver Microsomes

Published:2005 Issue:5 Volume:28 Page:882-885
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Nakamura Katsunori¹,Ariyoshi Noritaka¹,Iwatsubo Takafumi²,Fukunaga Yasuhisa²,Higuchi Saburou²,Itoh Kunio³,Shimada Noriaki³,Nagashima Kazuo⁴,Yokoi Tsuyoshi¹,Yamamoto Koujirou,Horiuchi Ryuya,Kamataki Tetsuya¹

Affiliation:

1. Laboratory of Drug Metabolism, Hokkaido University Graduate School of Pharmaceutical Sciences

2. Drug Metabolism Laboratories, Yamanouchi Pharmaceutical Co., Ltd.

3. Tokai Research Laboratories, Daiichi Pure Chemicals Co., Ltd.

4. Molecular and Cellular Pathology, Hokkaido University Graduate School of Medicine

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/28/5/28_5_882/_pdf

Reference21 articles.

1. 1) Present address: Department of Clinical Pharmacology and University Hospital Division of Pharmacy, Gunma University Graduate School of Medicine, Maebashi 371–8511, Japan.

2. 2) Present address: University Hospital Division pf Pharmacy, Chiba University School of Medicine, Chiba 263–8522, Japan.

3. 3) Present address: CAC Corporation, Tokyo 101–0003, Japan.

4. 4) Present address: The First Department of Pharmaceutics, Tohoku Pharmaceutical University, Sendai 981–8558, Japan.

5. 5) Present address: Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Kanazawa University Graduate School of Pharmaceutical Sciences, Kanazawa 920–0934, Japan.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nicardipine-chitosan nanoparticles alleviate thioacetamide-induced acute liver injury by targeting NFκB/NLRP3/IL-1β signaling in rats: Unraveling new roles beyond calcium channel blocking;International Immunopharmacology;2024-11

2. Clinical pharmacokinetics and pharmacodynamics of Nicardipine; a systematic review.;Expert Opinion on Drug Metabolism & Toxicology;2024-09-09

3. Optimization of a sensitive and reliable UPLC-MS/MS method to simultaneously quantify almonertinib and HAS-719 and its application to study the interaction with nicardipine;2024-03-27

4. Cardiac toxicity of phenanthrene depends on developmental stage in Atlantic cod (Gadus morhua);Science of The Total Environment;2023-07

5. CYP1A inhibitors: Recent progress, current challenges, and future perspectives;Medicinal Research Reviews;2023-06-19